Many biotech stocks have taken a beating over the last 12 months. That’s the bad news. But the good news is that major pullbacks in an industry can present great buying opportunities for investors with an eye on the future.
Many biotech stocks have taken a beating over the last 12 months. That’s the bad news. But the good news is that major pullbacks in an industry can present great buying opportunities for investors with an eye on the future.